Looming Antimicrobial Resistance Crisis: The Paradox of Non-Adherence to Cesarean Antibiotic Prophylaxis Guidelines in Ethiopia – A Commentary
DOI:
https://doi.org/10.69614/ejrh.v18i04.1157Abstract
Abstract
The administration of prophylactic antibiotics is a cornerstone of infection prevention for Cesarean sections (CS), with global and Ethiopian national guidelines recommending a single, pre-operative dose of narrow-spectrum ‘Access’ antibiotics like cefazolin. However, a significant "implementation gap" exists in Ethiopia, characterized by a systemic "Ceftriaxone shift". Despite national policy alignment with WHO standards, hospitals frequently replace recommended narrow-spectrum agents with broad-spectrum ‘Watch’ antibiotics, primarily ceftriaxone. Furthermore, the ‘single-dose’ standard is often abandoned in favor of extended postoperative regimens lasting 24–48 hours, reflecting near-total noncompliance.
This shift is driven by multifaceted factors: surgical teams’ fear of contamination, supply chain fragility causing inconsistent cefazolin availability, and hierarchical ‘prescribing etiquette’ where junior clinicians follow legacy practices. Paradoxically, despite this chemical overuse, surgical site infection rates remain high at 9% to 16%. This reliance on broad-spectrum agents worsens regional antimicrobial resistance (AMR), with multidrug-resistant (MDR) prevalence among Gram-negative bacilli reaching 82.7%. The risk extends to neonates, who are increasingly exposed to MDR pathogens through vertical transmission and hospital reservoirs.
To address this crisis, Ethiopia must shift from individual prescribing habits to systemic antimicrobial stewardship. This requires the Federal Ministry of Health to ensure consistent procurement of ‘Access’ agents, a pivot toward holistic surgical bundles rather than chemical overuse, and the implementation of local context-tailored trials to build clinician confidence in evidence-based practices.
References
Reference
Organization WH. Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization; 2016.
World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva: World Health Organization; 2022.
Federal Ministry of Health E. National Management Protocol on Selected Obstetrics Topics. Addis Ababa; 2021.
Federal Ministry of Health E. Ethiopian Essential Medicines List, 6th Edition. 6th Edition ed. Addis Ababa: Federal Ministry of Health, Ethiopia; 2024.
Ferede YA, Alemu MA, Dagnew SB, Moges TA, Kassie AB, Zewdu WS, et al. Surgical Antibiotic Prophylaxis Utilization and Predictors of Surgical Site Infections at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: Prospective Cohort Study. BioMed Research International. 2026;2026(1):6612112.
Habteweld HA, Yimam M, Tsige AW, Wondmkun YT, Endalifer BL, Ayenew KD. Surgical site infection and antimicrobial prophylaxis prescribing profile, and its determinants among hospitalized patients in Northeast Ethiopia: a hospital based cross-sectional study. Scientific Reports. 2023;13(1):14689.
Muhammed OS, Nasir BB. Drug Use Evaluation of Ceftriaxone in Ras-Desta Memorial General Hospital, Ethiopia. Drug, Healthcare and Patient Safety. 2020;12(null):161-8.
Mammo TN, Feyssa MD, Nofal MR, Gebeyehu N, Shiferaw MA, Tesfaye A, et al. A Perioperative Quality Improvement Program for Cesarean Delivery in Ethiopia: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Netw Open. 2024;7(8):e2428910.
Abayneh M, Worku T. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia. Drug Target Insights. 2020;14:16-25.
Legese MH, Asrat D, Swedberg G, Hasan B, Mekasha A, Getahun T, et al. Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals. Antimicrobial Resistance & Infection Control. 2022;11(1):83.
Eshetu B, Gashaw M, Solomon S, Berhane M, Molla K, Abebe T, et al. Bacterial Isolates and Resistance Patterns in Preterm Infants with Sepsis in Selected Hospitals in Ethiopia: A Longitudinal Observational Study. Glob Pediatr Health. 2020;7:2333794x20953318.
Gurmu MW, Manahle S, T GM, Yinges SG, Agero G, Kebede L. Bacteriological profiles, antimicrobial resistance patterns, and predictors of culture-confirmed neonatal Sepsis at Asella Teaching Hospital, Southeast Ethiopia. PLoS One. 2026;21(3):e0345245.
Gashaw M, Ali S, Berhane M, Tesfaw G, Eshetu B, Workneh N, et al. Neonatal Sepsis Due to Multidrug-resistant Bacteria at a Tertiary Teaching Hospital in Ethiopia. Pediatr Infect Dis J. 2024;43(7):687-93.
J ON. Tackling?drug?resistant?infections?globally:?Final?report?and?recommendations. London,?UK; 2016.
Alemkere G, Tadeg H, Getahun W, Shewarega W, Agalu A, Joshi MP, et al. Optimizing prophylactic antibiotic use among surgery patients in Ethiopian hospitals. Journal of Infection and Public Health. 2023;16:82-9.
Alemkere G, Teshome A, Temesgen G, Abebe G, Degefaw Y, Tilahun H, et al. Cefazolin access and use in Ethiopia: A policy implication. PLOS Glob Public Health. 2023;3(1):e0001421.
Alemkere G, Tegegne GT, Molla GA, Belayneh A, Muzeyin H, Shewarega W, et al. Etiquette of the antibiotic decision-making process for surgical prophylaxis in Ethiopia: a triangulated ethnographic study. Front Public Health. 2023;11:1251692.
Wondmeneh TG, Mohammed JA. The incidence of surgical site infection and its predictors among women delivered via cesarean sections in Ethiopia: a systematic review and meta-analysis. Front Med (Lausanne). 2024;11:1395158.
Haas DM, Morgan S, Contreras K, Kimball S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2020;4(4):Cd007892.
